4 research outputs found
Rapid screening of cellular stress responses in recombinant Pichia pastoris strains using metabolite profiling
Heterologous protein production in the yeast Pichia pastoris can be limited by biological responses to high expression levels; the unfolded protein response (UPR) is a key determinant of the success of protein production in this organism. Here, we used untargeted NMR metabolic profiling (metabolomics) of a number of different recombinant strains, carried out in a miniaturized format suitable for screening-level experiments. We identified a number of metabolites (from both cell extracts and supernatants) which correlated well with UPR-relevant gene transcripts, and so could be potential biomarkers for future high-throughput screening of large numbers of P. pastoris clones.This study was wholly funded by the Bioprocessing Research Industry Club (BRIC), a partnership between
BBSRC, EPSRC and a consortium of leading companies (http://www.
bbsrc.ac.uk/business/collaborative-research/industry-clubs/bric/background.aspx, Grant reference BBF0049071)
Radiosynthesis of SPECT tracers via a copper mediated 123 I iodination of (hetero)aryl boron reagents
International audienceA general method for the copper mediated nucleophilic 123I-iodination of (hetero)aryl boronic esters and acids has been developed. The broad substrate scope of this radiosynthetic approach allows access to [123I]DPA-713, [123I]IMPY, [123I]MIBG and [123I]IPEB that are four commonly used SPECT radiotracers. Our results infer that aryl boronic reagents can now be employed as common precursors for both fluorine-18 and iodine-123 radiolabelling
Tc-99m-radiolabeled composites enabling in vivo imaging of arterial dispersal and retention of microspheres in the vascular network of rabbit lungs, liver, and liver tumors.
Purpose: Selective internal radiation therapy (SIRT) is an effective treatment option for liver
tumors, using Y-90-loaded polymer microspheres that are delivered via catheterization of the
hepatic artery. Since Y-90 is a beta emitter and not conveniently imaged by standard clinical
instrumentation, dosimetry is currently evaluated in each patient using a surrogate particle,
99mTechnetium-labeled macroaggregated albumin (99mTc-MAA). We report a new composite
consisting of 99mTc-labeled nanoparticles attached to the same polymer microspheres as used
for SIRT, which can be imaged with standard SPECT.
Methods: Carbon nanoparticles with an encapsulated core of 99mTc were coated with the polycation
protamine sulfate to provide electrostatic attachment to anionic polystyrene sulfonate
microspheres of different sizes (30, 12, and 8 µm). The in vivo stability of these composites was
determined via intravenous injection and entrapment in the capillary network of normal rabbit
lungs for up to 3 hours. Furthermore, we evaluated their biodistribution in normal rabbit livers,
and livers implanted with VX2 tumors, following intrahepatic artery instillation.
Results: We report distribution tests for three different sizes of radiolabeled microspheres and
compare the results with those obtained using 99mTc-MAA. Lung retention of the radiolabeled
microspheres ranged from 72.8% to 92.9%, with the smaller diameter microspheres showing
the lowest retention. Liver retention of the microspheres was higher, with retention in normal
livers ranging from 99.2% to 99.8%, and in livers with VX2 tumors from 98.2% to 99.2%. The
radiolabeled microspheres clearly demonstrated preferential uptake at tumor sites due to the
increased arterial perfusion produced by angiogenesis.
Conclusion: We describe a novel use of radiolabeled carbon nanoparticles to generate an
imageable microsphere that is stable in vivo under the shear stress conditions of arterial
networks. Following intra-arterial instillation in the normal rabbit liver, they distribute in a
distinct segmented pattern, with the smaller microspheres extending throughout the organ in
finer detail, while still being well retained within the liver. Furthermore, in livers hosting an
implanted VX2 tumor, they reveal the increased arterial perfusion of tumor tissue resulting from
angiogenesis. These novel composites may have potential as a more representative mimic of
the vascular distribution of therapeutic microspheres in patients undergoing SIRTThe ANU authors acknowledge the collaborative project support generously provided to ANU by Sirtex Medical Limited
(Sydney), including donation of a GE Hawkeye Infinia SPECT/
CT scanner and a Xeleris image processing system. This work
was funded through a collaborative research agreement with
Sirtex Medical Limited, Sydney, Australia
Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens
The discovery of the epigenetic regulation of transcription has provided a new source of mechanistic understanding to long lasting effects of chemicals. However, this information is still seldom exploited in a toxicological context and studies of chemical effect after washout remain rare. Here we studied the effects of two nephrocarcinogens on the human proximal tubule cell line RPTEC/TERT1 using high-content mRNA microarrays coupled with miRNA, histone acetylation (HA) and DNA methylation (DM) arrays and metabolomics during a 5-day repeat-dose exposure and 3 days after washout. The mycotoxin ochratoxin A (OTA) was chosen as a model compound for its known impact on HA and DM. The foremost effect observed was the modulation of thousands of mRNAs and histones by OTA during and after exposure. In comparison, the oxidant potassium bromate (KBrO3) had a milder impact on gene expression and epigenetics. However, there was no strong correlation between epigenetic modifications and mRNA changes with OTA while with KBrO3 the gene expression data correlated better with HA for both up-and down-regulated genes. Even when focusing on the genes with persistent epigenetic modifications after washout, only half were coupled to matching changes in gene expression induced by OTA, suggesting that while OTA causes a major effect on the two epigenetic mechanisms studied, these alone cannot explain its impact on gene expression. Mechanistic analysis confirmed the known activation of Nrf2 and p53 by KBrO3, while OTA inhibited most of the same genes, and genes involved in the unfolded protein response. A few miRNAs could be linked to these effects of OTA, albeit without clear contribution of epigenetics to the modulation of the pathways at large. Metabolomics revealed disturbances in amino acid balance, energy catabolism, nucleotide metabolism and polyamine metabolism with both chemicals. In conclusion, the large impact of OTA on transcription was confirmed at the mRNA level but also with two high-content epigenomic methodologies. Transcriptomic data confirmed the previously reported activation (by KBrO3) and inhibition (by OTA) of protective pathways. However, the integration of omic datasets suggested that HA and DM were not driving forces in the gene expression changes induced by either chemical.The study was funded by the 7th Framework project
DETECTIVE (grant no. 266838 to PJ, JK, AS, HK, and AK-S), the
Long Range Initiative Innovative Science Award of the European
Chemical Industry Council (CEFIC, 2015 to AL), the Horizon
2020 project EU-ToxRisk (http://www.eu-toxrisk.eu/ grant no.
681002, to PJ) and the Tiroler Wissenschaftfund (Grant no.
UNI-0404/1768, to AW)